|
Drug Monitoring and Toxicology
Citations 521-530 of 565 total displayed.
|
Past content
(since Jan 1997):
|
- Doping in Sport Symposium Proceedings
Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control
- Ulf-Håkan Stenman, Leila Unkila-Kallio, Juha Korhonen, and Henrik Alfthan
Clin. Chem. 1997; 43: 1293-1298.
[Abstract]
[Full text]
[PDF]
- Doping in Sport Symposium Proceedings
Analytical advances in detection of performance-enhancing compounds
- Larry D. Bowers
Clin. Chem. 1997; 43: 1299-1304.
[Abstract]
[Full text]
[PDF]
- Automation and Analytical Techniques
Highly sensitive gas chromatographic analysis of ethanol in whole blood, serum, urine, and fecal supernatants by the direct injection method
- Albert Tangerman
Clin. Chem. 1997; 43: 1003-1009.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Gastrointestinal absorption, tissue retention, and urinary excretion of dietary aluminum in rats determined by using 26Al
- Philippe Jouhanneau, Grant M. Raisbeck, Françoise Yiou, Bernard Lacour, Hélène Banide, and Tilman B. Drüeke
Clin. Chem. 1997; 43: 1023-1028.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Simultaneous identification and quantitation of codeine, morphine, hydrocodone, and hydromorphone in urine as trimethylsilyl and oxime derivatives by gas chromatographymass spectrometry
- Larry A. Broussard, Lance C. Presley, Thomas Pittman, Randy Clouette, and Gary H. Wimbish
Clin. Chem. 1997; 43: 1029-1032.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Evaluation of selected-ion storage ion-trap mass spectrometry for detecting urinary anabolic agents
- Larry D. Bowers and David J. Borts
Clin. Chem. 1997; 43: 1033-1039.
[Abstract]
[Full text]
[PDF]
- Technical Briefs
Determination of MEGX by HPLC with Fluorescence Detection
- Maria Andreeva, Paul Dieter Niedmann, Ekkehard Schütz, Eberhard Wieland, Victor William Armstrong, and Michael Oellerich
Clin. Chem. 1997; 43: 1081-1083.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Handling of Blood Samples for Determination of Thalidomide Two of the authors referred to respond:
- Tommy Eriksson, Sven Björkman, Andrew W. Lyon, and Vidmantas A. Raisys
Clin. Chem. 1997; 43: 1094-1096.
[Extract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Development of enzyme immunoassay for endogenous ouabain-like compound in human plasma
- Steven Harwood, John A. Little, Gerard Gallacher, David Perrett, Raymond Edwards, and Anne Dawnay
Clin. Chem. 1997; 43: 715-722.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds
- Joachim D. Pleil and Andrew B. Lindstrom
Clin. Chem. 1997; 43: 723-730.
[Abstract]
[Full text]
[PDF]
|
|